This site is intended for health professionals only

GSK in $40m China investment

teaser

GlaxoSmithKline intends to spend $40m this year on its new facility in Shanghai, China, which is expected to become one of the drug major






Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine

x